Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.06% | -28.60% | -7.83% | -75.27% | -58.18% |
| Total Depreciation and Amortization | 21.32% | -26.68% | -43.68% | -39.65% | -34.80% |
| Total Amortization of Deferred Charges | 28.78% | 84.71% | 81.06% | 2,507.23% | 2,980.77% |
| Total Other Non-Cash Items | 102.74% | 274.44% | 191.96% | 362.28% | 647.75% |
| Change in Net Operating Assets | 52.19% | 63.30% | 56.80% | 13.66% | 16.62% |
| Cash from Operations | 19,470.59% | 188.52% | 230.71% | 86.18% | 99.27% |
| Capital Expenditure | -1,712.09% | -1,887.81% | -918.38% | -511.14% | 25.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 78.66% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10,150.52% | -- | -- | -- | -- |
| Cash from Investing | -74.74% | -41.34% | -51.53% | -14.44% | 35.23% |
| Total Debt Issued | -14.82% | -14.82% | -49.49% | 170.21% | 45.67% |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.03% | -1,166.12% | -389.43% | 11.71% | -49.15% |
| Cash from Financing | -44.36% | -54.72% | 72.75% | 237.74% | 80.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74.66% | -93.21% | 11,895.89% | 500.60% | 381.52% |